코어 연구소 Inc.
DE ˙ DB ˙ US21867A1051
€11.00 ↓ -0.50 (-4.35%)
2026-06-05
주가
SecurityDE:HJ1 / Core Laboratories Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership232,001 shares
Latest Disclosed Value $ 3,895,297
Invesco Ltd. reports 13.62% increase in ownership of HJ1 / Core Laboratories Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 232,001 shares of Core Laboratories Inc. (DE:HJ1) valued at $3,340,814 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 204,194 shares of Core Laboratories Inc.. This represents a change in shares of 13.62% during the quarter. The current value of the position is $2,552,011 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CORE LABORATORIES COM 21867A105 232,001 27,807 13.62 3,895 19.00 0.0006
2026-02-19 2025-12-31 13F CORE LABORATORIES COM 21867A105 204,194 -10,324 -4.81 3,273 23.46 0.0005
2025-11-13 2025-09-30 13F CORE LABORATORIES COM 21867A105 214,518 -15,150 -6.60 2,651 0.23 0.0004
2025-08-13 2025-06-30 13F CORE LABORATORIES COM 21867A105 229,668 -4,225 -1.81 2,646 -24.56 0.0004
2025-05-12 2025-03-31 13F CORE LABORATORIES COM 21867A105 233,893 -18,431 -7.30 3,506 -19.72 0.0007
2025-02-13 2024-12-31 13F CORE LABORATORIES COM 21867A105 252,324 -84,510 -25.09 4,368 -30.03 0.0008
2024-11-12 2024-09-30 13F CORE LABORATORIES COM 21867A105 336,834 16,142 5.03 6,242 -4.07 0.0012
2024-08-13 2024-06-30 13F CORE LABORATORIES COM 21867A105 320,692 -89,981 -21.91 6,507 -7.24 0.0014
2024-05-14 2024-03-31 13F CORE LABORATORIES COM 21867A105 410,673 -1,811 -0.44 7,014 -3.71 0.0015
2024-02-13 2023-12-31 13F CORE LABORATORIES COM 21867A105 412,484 -23,975 -5.49 7,284 -30.49 0.0017
2023-11-13 2023-09-30 13F CORE LABORATORIES COM 21867A105 436,459 88,013 25.26 10,479 29.35 0.0028
2023-08-11 2023-06-30 13F CORE LABORATORIES COM 21867A105 348,446 -21,591 -5.83 8,101 -0.71 0.0021
2023-05-12 2023-03-31 13F CORE LABORATORIES N V COM N22717107 370,037 61,193 19.81 8,159 30.34 0.0023
2023-02-13 2022-12-31 13F CORE LABORATORIES N V COM N22717107 308,844 7,768 2.58 6,260 54.26 0.0018
2022-11-14 2022-09-30 13F CORE LABORATORIES N V COM N22717107 301,076 -51,299 -14.56 4,058 -41.86 0.0013
2022-08-15 2022-06-30 13F CORE LABORATORIES N V COM N22717107 352,375 5,898 1.70 6,980 -36.31 0.0021
2022-05-16 2022-03-31 13F CORE LABORATORIES N V COM N22717107 346,477 125,140 56.54 10,959 121.93 0.0028
2022-02-14 2021-12-31 13F CORE LABORATORIES N V COM N22717107 221,337 -9,689 -4.19 4,938 -22.98 0.0012
2021-11-15 2021-09-30 13F CORE LABORATORIES N V COM N22717107 231,026 -295,298 -56.11 6,411 -68.73 0.0016
2021-08-17 2021-06-30 13F CORE LABORATORIES N V COM N22717107 526,324 177,775 51.00 20,500 104.29 0.0050
2021-05-17 2021-03-31 13F CORE LABORATORIES N V COM N22717107 348,549 161,337 86.18 10,035 102.20 0.0027
2021-02-16 2020-12-31 13F CORE LABORATORIES N V COM N22717107 187,212 3,456 1.88 4,963 77.00 0.0014
2020-11-16 2020-09-30 13F CORE LABORATORIES N V COM N22717107 183,756 10,773 6.23 2,804 -20.23 0.0009
2020-08-14 2020-06-30 13F CORE LABORATORIES N V COM N22717107 172,983 -106,093 -38.02 3,515 21.84 0.0013
2020-05-15 2020-03-31 13F CORE LABORATORIES N V COM N22717107 279,076 125,032 81.17 2,885 -50.28 0.0012
2020-02-14 2019-12-31 13F CORE LABORATORIES N V COM N22717107 154,044 -5,802 -3.63 5,803 -22.13 0.0018
2019-11-14 2019-09-30 13F CORE LABORATORIES N V COM N22717107 159,846 -395,591 -71.22 7,452 -74.34 0.0019
2019-08-14 2019-06-30 13F/A-1 CORE LABORATORIES N V COM N22717107 555,437 -23,016 -3.98 29,038 -27.18 0.0075
2019-08-14 2019-06-30 13F CORE LABORATORIES N V COM N22717107 555,437 -577,453 29,038
2019-05-15 2019-03-31 13F CORE LABORATORIES N V COM N22717107 578,453 9,474 1.67 39,874 17.47 0.0134
2019-02-14 2018-12-31 13F CORE LABORATORIES N V COM N22717107 568,979 -8,143 -1.41 33,945 -49.22 0.0130
2018-11-14 2018-09-30 13F CORE LABORATORIES N V COM N22717107 577,122 -40,319 -6.53 66,846 -14.22 0.0210
2018-08-14 2018-06-30 13F CORE LABORATORIES N V COM N22717107 617,441 186,507 43.28 77,927 67.10 0.0258
2018-05-15 2018-03-31 13F CORE LABORATORIES N V COM N22717107 430,934 -77,290 -15.21 46,636 -16.24 0.0174
2018-02-14 2017-12-31 13F CORE LABORATORIES N V COM N22717107 508,224 -8,882 -1.72 55,677 9.09 0.0201
2017-11-14 2017-09-30 13F CORE LABORATORIES N V COM N22717107 517,106 -6,305 -1.20 51,040 -3.71 0.0189
2017-08-14 2017-06-30 13F CORE LABORATORIES N V COM N22717107 523,411 -14,151 -2.63 53,006 -14.64 0.0165
2017-05-15 2017-03-31 13F CORE LABORATORIES N V COM N22717107 537,562 -2,255 -0.42 62,100 -4.17 0.0204
2017-02-14 2016-12-31 13F CORE LABORATORIES N V COM N22717107 539,817 -6,716 -1.23 64,799 5.55 0.0218
2016-11-14 2016-09-30 13F CORE LABORATORIES N V COM N22717107 546,533 -20,083 -3.54 61,392 -12.54 0.0211
2016-08-15 2016-06-30 13F CORE LABORATORIES N V COM N22717107 566,616 -49,894 -8.09 70,198 1.29 0.0258
2016-05-16 2016-03-31 13F CORE LABORATORIES N V COM N22717107 616,510 37,311 6.44 69,301 10.03 0.0282
2016-02-16 2015-12-31 13F CORE LABORATORIES N V COM N22717107 579,199 129,708 28.86 62,982 40.40 0.0251
2015-11-16 2015-09-30 13F CORE LABORATORIES N V COM N22717107 449,491 149,262 49.72 44,860 31.02 0.0190
2015-08-14 2015-06-30 13F CORE LABORATORIES N V COMMON N22717107 300,229 -172,034 -36.43 34,238 -30.62 0.0134
2015-05-15 2015-03-31 13F CORE LABORATORIES N V COMMON N22717107 472,263 336,759 248.52 49,348 202.62 0.0191
2015-02-13 2014-12-31 13F CORE LABORATORIES N V COMMON N22717107 135,504 50,969 60.29 16,307 31.81 0.0063
2014-11-14 2014-09-30 13F CORE LABORATORIES N V COMMON N22717107 84,535 10,070 13.52 12,372 -0.55 0.0049
2014-08-14 2014-06-30 13F CORE LABORATORIES N V COMMON N22717107 74,465 -9,164 -10.96 12,440 -25.04 0.0049
2014-05-15 2014-03-31 13F CORE LABORATORIES N V COMMON N22717107 83,629 25,657 44.26 16,595 49.92 0.0067
2014-02-13 2013-12-31 13F CORE LABORATORIES N V COMMON N22717107 57,972 7,856 15.68 11,069 30.53 0.0044
2013-11-13 2013-09-30 13F CORE LABORATORIES N V COMMON N22717107 50,116 -19,154 -27.65 8,480 -19.28 0.0037
2013-08-14 2013-06-30 13F CORE LABORATORIES N V COMMON N22717107 69,270 69,270 10,505 0.0049
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.